Skip to main content
. 2019 Jun 5;2019(6):CD009670. doi: 10.1002/14651858.CD009670.pub4

Powers 2016.

Trial name or title Efficacy of smoking cessation therapy alone or integrated with prolonged exposure therapy for smokers with PTSD
Methods Study design: randomised controlled trial
Setting: USA
Recruitment: smokers with post‐traumatic stress disorder aged between 18 and 64 years selected for motivation to quit
Participants 80 participants
Interventions Pharmacotherapy: nicotine patch
1. Standard smoking cessation treatment: once‐weekly 45‐minute sessions of cognitive behavioural therapy over a 12‐week period
2. Integrated PTSD and smoking treatment: once‐weekly 90‐minute sessions over a 12‐week period. Incorporated standard treatment with therapy for reducing PTSD symptoms and anxiety sensitivity and enhancing tolerance for nicotine withdrawal sensations.
Outcomes Abstinence at 24 weeks
Validation: saliva cotinine < 10ng/mL for stated abstinence of 2 weeks or more, carbon monoxide analysis of breath samples < 8ppm for stated abstinence of 24 hours to 2 weeks
Starting date October 2013
Contact information Mark B Powers, University of Texas
Notes